Improving Hand Recovery With Neuromodulation in Tetraplegia (IGNITE)

June 18, 2021 updated by: Sara Shahid Salles
This study will examine a form of non-invasive brain stimulation applied with intensive therapy of the arm and hand. The goal of the study is to determine if arm and hand function can be improved in people with incomplete cervical spinal cord injury (neck spinal cord injury, tetraplegia). Participants will be assigned to receive either active or inactive non-invasive brain stimulation.

Study Overview

Detailed Description

This study will look at the effects of a painless, non-invasive form of brain stimulation, called transcranial direct current stimulation, or tDCS. tDCS is thought to increase the brain's ability to change. Participants will be assigned to one of two groups by chance. One group will receive tDCS at a level expected to increase the brain's ability to change, while the other group will receive tDCS at a level not thought to affect the brain's ability to change. All participants will receive intensive therapy of their more impaired arm and hand, focusing on exercises that are meaningful to him/her.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Lexington, Kentucky, United States, 40504
        • University of Kentucky at Cardinal Hill Rehabilitation Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. traumatic, incomplete cervical SCI sustained at neurological level C4-C7 and classified as B, C or D by the American Spinal Injury Association Impairment Scale (AIS);
  2. sustained injury at least 1 year prior to enrollment (i.e., chronic); and
  3. Men and women between the ages of 18-65.

Exclusion Criteria:

  1. history of head injury, seizures, severe alcohol or drug abuse, or psychiatric illness;
  2. cognitive deficits severe enough to preclude informed consent;
  3. positive pregnancy test or being of childbearing age and not using appropriate contraception;
  4. presence of ferromagnetic material in the cranium except in the mouth, including metal fragments from occupational exposure and surgical clips in or near the brain;
  5. decubitus ulcers that might interfere with intervention;
  6. cardiac or neural pacemakers;
  7. fixed UE contractures;
  8. untreated depression;
  9. concurrent participation in occupational therapy;
  10. within 3 months of recruitment, an addition or change in the dosage of drugs known to exert detrimental effects on motor recovery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active tDCS
Subjects will receive 20 minutes of active transcranial direct current stimulation at 2.5mA, followed by 2 hours of intensive motor therapy of the more affected upper extremity.
This is a non-invasive form of stimulation which delivers safe, low levels of electrical current to the brain through the scalp.
This training is administered one-on-one with an occupational therapist. Activities will be focused on skills the participant wants to regain.
Sham Comparator: Sham tDCS
Subjects will receive 20 minutes of sham transcranial direct current stimulation, followed by 2 hours of intensive motor therapy of the more affected upper extremity.
This is a non-invasive form of stimulation which delivers safe, low levels of electrical current to the brain through the scalp.
This training is administered one-on-one with an occupational therapist. Activities will be focused on skills the participant wants to regain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Spinal Cord Independence Measure
Time Frame: Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
This evaluates self-care, respiration and sphincter management, and mobility.
Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Medical Research Council Scale Upper Extremity Manual Muscle Test
Time Frame: Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
This evaluates the strength of various muscles in the upper extremity. Each muscle that is tested can be scored from a minimum of 0, indicating no strength, up to a maximum of 5, indicating normal strength. Scores are assigned to each side by summing the scores from each of the 41 individual muscles, with a minimum possible total score of 0 and a maximum possible total score of 205. Higher values indicate greater strength.
Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
Change in Canadian Occupational Performance Measure
Time Frame: Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
The participant selects 5 tasks they would like to be able to perform, and score their performance as well as satisfaction with their performance of the tasks.
Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
Change in Graded and Redefined Assessment of Strength, Sensibility, and Prehension
Time Frame: Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
This measures strength, sensibility, and prehension to obtain information about motor and sensory function.
Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
Change in Van Lieshout Test
Time Frame: Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
This test evaluates upper extremity motor performance in cervical spinal cord injury.
Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
Change in cortical motor map volume
Time Frame: Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
This is performed using non-invasive transcranial magnetic stimulation to determine which parts of the brain control a muscle in the arm or hand.
Change from baseline at immediately post-intervention, 1-month follow-up, 4-month follow-up
Semi-structured interview about study
Time Frame: Baseline
Participants will be asked about motivations and goals for the study.
Baseline
Semi-structured interview about study
Time Frame: Immediately post-intervention, 4-month follow-up
Participants will be asked about their experience in the study, whether they experienced any changes in function during the study, and whether they have recommendations for change.
Immediately post-intervention, 4-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Sara Salles, MD, University of Kentucky

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2019

Primary Completion (Actual)

March 24, 2020

Study Completion (Actual)

March 24, 2020

Study Registration Dates

First Submitted

May 14, 2019

First Submitted That Met QC Criteria

May 15, 2019

First Posted (Actual)

May 17, 2019

Study Record Updates

Last Update Posted (Actual)

June 24, 2021

Last Update Submitted That Met QC Criteria

June 18, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on transcranial direct current stimulation

3
Subscribe